Tumour microenvironment immune markers associated with pathologic response to neoadjuvant pembrolizumab in muscle-invasive bladder cancer (Pure-01 trial: an open label, single arm, Phase II study)
VIRCHOWS ARCHIV(2022)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined